AMENDING AGREEMENT #1Amending Agreement • March 19th, 2018 • Oncolytics Biotech Inc • Pharmaceutical preparations • California
WHEREAS the Employee is an officer of OBUS whose terms of employment are set forth in the Employment Agreement ("Employment Agreement") dated effective June 29, 2017;
AMENDING AGREEMENT #5Amending Agreement • March 19th, 2018 • Oncolytics Biotech Inc • Pharmaceutical preparations • Alberta
WHEREAS the Employee is an officer of Oncolytics whose terms of employment are set forth in the Executive Employment Agreement ("Employment Agreement") dated effective January 1, 2013 as amended by an Amending Agreement #1 dated March 12, 2014, Amending Agreement #2 dated March 12, 2015, Amending Agreement #3 dated March 8, 2016, and Amending Agreement #4 dated February 23, 2017 (together the "Employment Agreement");
LICENSE, DEVELOPMENT, SUPPLY AND DISTRIBUTION AGREEMENTAnd Distribution Agreement • March 19th, 2018 • Oncolytics Biotech Inc • Pharmaceutical preparations • Hong Kong
Oncolytics and Licensee are referred to from time to time herein individually as a “Party” or collectively as the “Parties”.
AMENDING AGREEMENT #5Amending Agreement • March 19th, 2018 • Oncolytics Biotech Inc • Pharmaceutical preparations • Alberta
WHEREAS the Employee is an officer of Oncolytics whose terms of employment are set forth in the Executive Employment Agreement dated effective January 1, 2013, as amended by an Amending Agreement #1 dated March 12, 2014, Amending Agreement #2 dated March 12, 2015, Amending Agreement #3 dated March 8, 2016, and Amending Agreement #4 dated February 23, 2017 (together the "Employment Agreement");
EMPLOYMENT AGREEMENTEmployment Agreement • March 19th, 2018 • Oncolytics Biotech Inc • Pharmaceutical preparations • California
AMENDING AGREEMENT #1Amending Agreement • March 19th, 2018 • Oncolytics Biotech Inc • Pharmaceutical preparations • California
WHEREAS the Employee is an officer of OBUS whose terms of employment are set forth in the Employment Agreement ("Employment Agreement") dated effective October 27, 2016;
